nitrites has been researched along with Diabetic Glomerulosclerosis in 22 studies
Nitrites: Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M=metal) are all insoluble, except the alkali nitrites. The organic nitrites may be isomeric, but not identical with the corresponding nitro compounds. (Grant & Hackh's Chemical Dictionary, 5th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with fenofibrate significantly improved the renal function as revealed by the significant reductions in urinary albumin excretion and serum levels of creatinine and urea, in addition to the significant increase in creatinine clearance compared with the diabetic control group." | 1.42 | Renoprotective Effects of Fenofibrate via Modulation of LKB1/AMPK mRNA Expression and Endothelial Dysfunction in a Rat Model of Diabetic Nephropathy. ( Al-Ajmi, HN; Al-Amin, MA; Al-Rasheed, NM; Attia, HA; Hasan, IH; Mohamad, RA; Sinjilawi, NA, 2015) |
| "Thermal hyperalgesia and mechanical allodynia were measured using planter test and dynamic aesthesiometer (Ugo-Basile, Italy), respectively." | 1.38 | Possible mechanism of protective effect of thalidomide in STZ-induced-neuropathic pain behavior in rats. ( Sharma, PL; Taliyan, R, 2012) |
| "Treatment with sodium nitrite (NO donor), L: -arginine (NO precursor), daidzein (caveolin inhibitor), and combination of L: -arginine and daidzein for 2 weeks markedly attenuated these changes and increased serum nitrite/nitrate ratio." | 1.37 | Involvement of vascular endothelial nitric oxide synthase in development of experimental diabetic nephropathy in rats. ( Arya, A; Sharma, PL; Yadav, HN, 2011) |
| " In conclusion, while NO bioavailability in mTALs is reduced during diabetes, free radical scavenging with tempol unmasks increased NO production that involves PP2B-dependent activation of NOS1 and NOS2." | 1.35 | PP2B-dependent NO production in the medullary thick ascending limb during diabetes. ( Carmines, PK; Foster, JM; Pollock, JS, 2009) |
| " These results indicate that dietary nitrite is effective in the prevention of early diabetic glomerular injury in which NO bioavailability is impaired." | 1.34 | Dietary nitrite inhibits early glomerular injury in streptozotocin-induced diabetic nephropathy in rats. ( Ishiyama, Y; Kobayashi, J; Muraki, E; Ohtake, K; Uchida, H, 2007) |
| "Diabetic nephropathy was exacerbated drastically by a nitric oxide synthase inhibitor and mildly by a NO precursor." | 1.33 | Chronic inhibition of nitric oxide production aggravates diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty rats. ( Higuchi, M; Hora, K; Kamijo, H, 2006) |
| "Gliclazide treatment, but not glibenclamide, significantly reduced the oxidative products and NAD(P)H oxidase." | 1.32 | Radical scavenging effect of gliclazide in diabetic rats fed with a high cholesterol diet. ( Fujita, T; Goto, A; Onozato, ML; Tojo, A, 2004) |
| "The rats with diabetic acute renal failure had a much lower creatinine clearance (90 +/- 22 microliters." | 1.29 | Nitric oxide in ischaemic acute renal failure of streptozotocin diabetic rats. ( Blum, M; Cabili, S; Chernihovsky, T; Goor, Y; Iaina, A; Peer, G; Silverberg, D; Wollman, Y, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 12 (54.55) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| You, H | 1 |
| Gao, T | 1 |
| Cooper, TK | 1 |
| Morris, SM | 1 |
| Awad, AS | 1 |
| Morsy, MA | 1 |
| Heeba, GH | 1 |
| Mahmoud, ME | 1 |
| Al-Rasheed, NM | 2 |
| Attia, HA | 1 |
| Al-Amin, MA | 1 |
| Al-Ajmi, HN | 1 |
| Hasan, IH | 1 |
| Mohamad, RA | 1 |
| Sinjilawi, NA | 1 |
| Okada, S | 1 |
| Saito, M | 1 |
| Kazuyama, E | 1 |
| Hanada, T | 1 |
| Kawaba, Y | 1 |
| Hayashi, A | 1 |
| Satoh, K | 1 |
| Kanzaki, S | 1 |
| Mariee, AD | 1 |
| Abd-Allah, GM | 1 |
| El-Yamany, MF | 1 |
| Foster, JM | 1 |
| Carmines, PK | 1 |
| Pollock, JS | 1 |
| Hsu, BR | 1 |
| Fu, SH | 1 |
| Hsu, S | 1 |
| Chen, ST | 1 |
| Arya, A | 1 |
| Yadav, HN | 1 |
| Sharma, PL | 2 |
| Taliyan, R | 1 |
| Imanishi, M | 1 |
| Okada, N | 1 |
| Konishi, Y | 1 |
| Morikawa, T | 1 |
| Maeda, I | 1 |
| Kitabayashi, C | 1 |
| Masada, M | 1 |
| Shirahashi, N | 1 |
| Wilcox, CS | 2 |
| Nishiyama, A | 1 |
| Palanisamy, N | 1 |
| Venkataraman, AC | 1 |
| Hiragushi, K | 2 |
| Wada, J | 2 |
| Eguchi, J | 1 |
| Matsuoka, T | 1 |
| Yasuhara, A | 1 |
| Hashimoto, I | 1 |
| Yamashita, T | 1 |
| Hida, K | 1 |
| Nakamura, Y | 1 |
| Shikata, K | 2 |
| Minamino, N | 1 |
| Kangawa, K | 1 |
| Makino, H | 2 |
| Onozato, ML | 2 |
| Tojo, A | 2 |
| Goto, A | 2 |
| Fujita, T | 2 |
| Asaba, K | 1 |
| Quinn, MT | 1 |
| Kamijo, H | 1 |
| Higuchi, M | 1 |
| Hora, K | 1 |
| Vareniuk, I | 1 |
| Pavlov, IA | 1 |
| Drel, VR | 1 |
| Lyzogubov, VV | 1 |
| Ilnytska, O | 1 |
| Bell, SR | 1 |
| Tibrewala, J | 1 |
| Groves, JT | 1 |
| Obrosova, IG | 1 |
| Ohtake, K | 1 |
| Ishiyama, Y | 1 |
| Uchida, H | 1 |
| Muraki, E | 1 |
| Kobayashi, J | 1 |
| Goor, Y | 1 |
| Peer, G | 1 |
| Iaina, A | 1 |
| Blum, M | 1 |
| Wollman, Y | 1 |
| Chernihovsky, T | 1 |
| Silverberg, D | 1 |
| Cabili, S | 1 |
| Trachtman, H | 2 |
| Futterweit, S | 2 |
| Crimmins, DL | 1 |
| Sugimoto, H | 1 |
| Matsuda, M | 1 |
| Kushiro, M | 1 |
| Hayashi, Y | 1 |
| De Vriese, AS | 1 |
| Stoenoiu, MS | 1 |
| Elger, M | 1 |
| Devuyst, O | 1 |
| Vanholder, R | 1 |
| Kriz, W | 1 |
| Lameire, NH | 1 |
| Pine, E | 1 |
| Mann, J | 1 |
| Valderrama, E | 1 |
1 trial available for nitrites and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Angiotensin II receptor blockade reduces salt sensitivity of blood pressure through restoration of renal nitric oxide synthesis in patients with diabetic nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Albuminuria; Angiotensin Receptor Antagonists; Biopterins; Blood Pressu | 2013 |
21 other studies available for nitrites and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Diabetic nephropathy is resistant to oral L-arginine or L-citrulline supplementation.
Topics: Amino Acids; Animals; Arginase; Arginine; Blood Pressure; Citrulline; Diabetes Mellitus, Experimenta | 2014 |
Ameliorative effect of eprosartan on high-fat diet/streptozotocin-induced early diabetic nephropathy in rats.
Topics: Acrylates; Angiotensin II; Animals; Blood Glucose; Catalase; Cholesterol; Collagen Type IV; Diabetic | 2015 |
Renoprotective Effects of Fenofibrate via Modulation of LKB1/AMPK mRNA Expression and Endothelial Dysfunction in a Rat Model of Diabetic Nephropathy.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Blood Glucose; Diabeti | 2015 |
Effects of N-hexacosanol on nitric oxide synthase system in diabetic rat nephropathy.
Topics: Animals; Diabetic Nephropathies; Fatty Alcohols; Gene Expression Regulation, Enzymologic; Immunoblot | 2008 |
Renal oxidative stress and nitric oxide production in streptozotocin-induced diabetic nephropathy in rats: the possible modulatory effects of garlic (Allium sativum L.).
Topics: Analysis of Variance; Animals; Diabetic Nephropathies; Garlic; Glutathione; Kidney; Male; Nitric Oxi | 2009 |
PP2B-dependent NO production in the medullary thick ascending limb during diabetes.
Topics: Amidines; Animals; Benzylamines; Calcineurin; Calcineurin Inhibitors; Cell Survival; Cyclic N-Oxides | 2009 |
Interleukin-1 receptor antagonist enhances islet engraftment without impacting serum levels of nitrite or osteopontin.
Topics: Adenoviridae; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; DNA, Complementary; | 2009 |
Involvement of vascular endothelial nitric oxide synthase in development of experimental diabetic nephropathy in rats.
Topics: Animals; Arginine; Blood Glucose; Blood Urea Nitrogen; Body Weight; Caveolin 1; Cholesterol; Collage | 2011 |
Possible mechanism of protective effect of thalidomide in STZ-induced-neuropathic pain behavior in rats.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Blood Glucose; Diabetes Mellitus, Experimental; Diabe | 2012 |
Beneficial effect of genistein on lowering blood pressure and kidney toxicity in fructose-fed hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Diabetic Nephropathies; Diet; Dietary Sucrose; Fru | 2013 |
The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats.
Topics: Adrenomedullin; Animals; Aorta; Blood Glucose; Blotting, Northern; Cells, Cultured; Diabetes Mellitu | 2004 |
Radical scavenging effect of gliclazide in diabetic rats fed with a high cholesterol diet.
Topics: Animals; Blood Pressure; Cholesterol, Dietary; Diabetes Mellitus, Experimental; Diabetic Nephropathi | 2004 |
Effects of NADPH oxidase inhibitor in diabetic nephropathy.
Topics: Acetophenones; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; | 2005 |
Chronic inhibition of nitric oxide production aggravates diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty rats.
Topics: Animals; Arginine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enzyme Inhibitors; Kidney Glom | 2006 |
Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice.
Topics: Anesthesia; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; | 2007 |
Dietary nitrite inhibits early glomerular injury in streptozotocin-induced diabetic nephropathy in rats.
Topics: Animals; Diabetic Nephropathies; Dietary Supplements; Kidney; Kidney Diseases; Male; Malondialdehyde | 2007 |
Nitric oxide in ischaemic acute renal failure of streptozotocin diabetic rats.
Topics: Acute Kidney Injury; Analysis of Variance; Animals; Arginine; Creatinine; Diabetes Mellitus, Experim | 1996 |
High glucose inhibits nitric oxide production in cultured rat mesangial cells.
Topics: Amino Acids; Animals; Arginine; Cells, Cultured; Diabetic Nephropathies; Glomerular Mesangium; Gluco | 1997 |
Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy.
Topics: Animals; Arterioles; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelium, Vascular; | 1998 |
Diabetes-induced microvascular dysfunction in the hydronephrotic kidney: role of nitric oxide.
Topics: Animals; Blood Vessels; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Nephropathi | 2001 |
Chronic diabetic nephropathy: role of inducible nitric oxide synthase.
Topics: Animals; Blood Glucose; Body Weight; Chronic Disease; Diabetic Nephropathies; Growth; Immunoblotting | 2002 |